Literature DB >> 19030193

Segmental colitis associated with diverticulosis syndrome.

Hugh-James Freeman1.   

Abstract

An inflammatory process that involves the sigmoid colonic segment associated with diverticular disease (SCAD) appears to be a distinct clinical and pathological disorder. It has been described in older adults, often presenting with rectal bleeding. Most of the patients seem to respond to treatment only with a 5-aminosalicylate, but some spontaneously resolve with no treatment. Endoscopic evaluation usually shows a non-specific inflammatory process localized in the sigmoid colon alone that may resolve completely with histologically normal colonic mucosa. Repeated symptomatic events with discrete episodes of segmental colitis may occur, but most patients have an entirely benign clinical course. Definition of the underlying molecular events that occur with SCAD may be critically important in understanding the critical elements present in a colonic inflammatory process that can completely resolve without pharmacological or biological treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030193      PMCID: PMC2773327          DOI: 10.3748/wjg.14.6442

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly.

Authors:  M A Peppercorn
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

2.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

3.  Granuloma-positive Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  Crohn's colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn's colitis.

Authors:  N S Goldstein; C Leon-Armin; A Mani
Journal:  Am J Surg Pathol       Date:  2000-05       Impact factor: 6.394

5.  Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance.

Authors:  S Gore; N A Shepherd; S P Wilkinson
Journal:  Int J Colorectal Dis       Date:  1992-06       Impact factor: 2.571

6.  Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII).

Authors:  G Imperiali; G Meucci; C Alvisi; R Fasoli; A Ferrara; C M Girelli; F Rocca; S Saibeni; G Minoli
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

7.  The pathology of diverticulosis coli.

Authors:  A Brian West; Mariela Losada
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

8.  Is segmental colitis a complication of diverticular disease?

Authors:  G E Sladen; M I Filipe
Journal:  Dis Colon Rectum       Date:  1984-08       Impact factor: 4.585

9.  Diverticular colitis - therapeutic and aetiological considerations.

Authors:  J. P Evans; J Cooper; W. E. W Roediger
Journal:  Colorectal Dis       Date:  2002-05       Impact factor: 3.788

10.  Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome).

Authors:  Hugh J Freeman
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

  10 in total
  2 in total

1.  Spectrum of non-inflammatory bowel disease and non-infectious colitis.

Authors:  Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

2.  Prevalence of Segmental Colitis Associated with Colonic Diverticulosis in a Prospective Cohort of Patients Who Underwent Colonoscopy in a Tertiary Center.

Authors:  Francesca Falangone; Gianluca Esposito; Stefano Angeletti; Emanuela Pilozzi; Vito Domenico Corleto; Emilio Di Giulio; Bruno Annibale; Marilia Carabotti
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.